Litigation Details for Ferring Pharmaceuticals Inc. v. Eugia Pharma Specialties Ltd. (D. Del. 2022)
✉ Email this page to a colleague
Ferring Pharmaceuticals Inc. v. Eugia Pharma Specialties Ltd. (D. Del. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-01-04 |
| Court | District Court, D. Delaware | Date Terminated | 2024-06-07 |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Patents | 9,415,085; 9,579,359 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Ferring Pharmaceuticals Inc. v. Eugia Pharma Specialties Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Ferring Pharmaceuticals Inc. v. Eugia Pharma Specialties Ltd. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-01-04 | 1 | Complaint | States Patent Number 9,415,085 prior to the expiration date of United States Patent Number 9,415,085 and…Number 9,415,085 (“the ’085 patent”), United States Patent Number 10,695,398 (“the ’398 patent”), United…United States Patent Number 9,415,085 will infringe one or more claims of United States Patent Number 9,…declaration that the claims of United States Patent Number 9,415,085 are valid and enforceable; …before the expiration of United States Patent Number 9,415,085 was an act of infringement under 35 U. | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
